MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,345,000 | -5.2% | 157,106 | -44.2% | 0.14% | -23.5% |
Q3 2019 | $14,075,000 | +75.0% | 281,500 | +27.1% | 0.19% | +87.0% |
Q2 2019 | $8,043,000 | +110.8% | 221,500 | +62.3% | 0.10% | +104.1% |
Q1 2019 | $3,815,000 | +46.1% | 136,500 | 0.0% | 0.05% | +22.5% |
Q4 2018 | $2,612,000 | -36.0% | 136,500 | 0.0% | 0.04% | -25.9% |
Q3 2018 | $4,083,000 | +0.7% | 136,500 | +23.5% | 0.05% | -15.6% |
Q2 2018 | $4,056,000 | +39.9% | 110,500 | +25.6% | 0.06% | +30.6% |
Q1 2018 | $2,899,000 | +20.5% | 88,000 | 0.0% | 0.05% | +16.7% |
Q4 2017 | $2,406,000 | -36.3% | 88,000 | -13.7% | 0.04% | -36.4% |
Q3 2017 | $3,778,000 | +10.4% | 102,000 | +13.3% | 0.07% | +3.1% |
Q2 2017 | $3,421,000 | -9.1% | 90,000 | +16.9% | 0.06% | -12.3% |
Q1 2017 | $3,765,000 | +7.7% | 77,000 | -25.2% | 0.07% | -8.8% |
Q4 2016 | $3,496,000 | -6.4% | 103,000 | +4.0% | 0.08% | -11.1% |
Q3 2016 | $3,736,000 | +48.1% | 99,000 | +32.0% | 0.09% | +36.4% |
Q2 2016 | $2,522,000 | +6.4% | 75,000 | 0.0% | 0.07% | +11.9% |
Q1 2016 | $2,370,000 | +0.3% | 75,000 | +18.5% | 0.06% | -6.3% |
Q4 2015 | $2,364,000 | -1.6% | 63,300 | 0.0% | 0.06% | +6.8% |
Q3 2015 | $2,403,000 | +5.0% | 63,300 | -20.9% | 0.06% | +22.9% |
Q2 2015 | $2,289,000 | -29.0% | 80,000 | -30.4% | 0.05% | -26.2% |
Q1 2015 | $3,223,000 | +55.3% | 115,000 | +53.3% | 0.06% | +51.2% |
Q4 2014 | $2,075,000 | – | 75,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERBACK ASSET MANAGEMENT LLC | 50,000 | $12,888,000 | 2.74% |
GLENMEDE TRUST CO NA | 784 | $66,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |